← Product catalog
C-090

Human Triple Negative Breast Cancer Organoid

Human Triple Negative Breast Cancer Organoid is a 3D in vitro model derived from patient tumors or established cell lines that lack ER, PR, and HER2 expression. It faithfully recapitulates the aggressive behavior, genetic profile, and heterogeneity of Triple-negative breast cancer, making it a valuable tool for studying tumor biology. It is widely used for drug screening, biomarker discovery, and the development of targeted therapies, particularly for this hard-to-treat breast cancer subtype. Organoids undergo rigorous testing for mycoplasma, bacteria, fungi/yeast, and are verified for identity, genetic stability, and functional performance.

Specifications

rank math seo score
10
rank math contentai score
a:5:{s:8:"keywords";s:5:"74.51";s:9:"wordCount";s:1:"0";s:9:"linkCount";s:1:"0";s:12:"headingCount";s:1:"0";s:10:"mediaCount";s:1:"0";}
product code
Human Triple Negative Breast Cancer Organoid; TNBC Organoid; Human Breast Cancer 3D Culture; Triple-Negative BC Organoid
cat no
C-090
disease
Cancer
organism
Human
tissue
Breast
growth properties
Embedded 3D Culture
biosafety level
1
growth conditions
37℃, 95% Air, 5% CO 2
size quantity
1
product format
Frozen
shipping info
Dry Ice
storage conditions
Liquid Nitrogen
quality control
All test negative for mycoplasma, bacteria, yeast, and fungi.
application
For research use only. Human Triple Negative Breast Cancer Organoid is an advanced in vitro model that mimics tumor heterogeneity and microenvironment, enabling studies of cancer development and progression. It is widely used for drug screening and personalized therapy, as well as gene function research through gene editing. Additionally, co-culture systems allow investigation of tumor–microenvironment interactions.